Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Blaiss

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 15, 2023
Real-world effectiveness of dupilumab in patients with asthma: Findings from the US ADVANTAGE studyMichael Blaiss, Eugene R Bleecker, Juby Jacob-Nara, et al.
The Journal of Allergy and Clinical Immunology|August 26, 2024
Comparative effectiveness of dupilumab and omalizumab on asthma exacerbations and systemic corticosteroid prescriptions: Real-world US ADVANTAGE studyEugene Bleecker, Michael Blaiss, Juby Jacob-Nara, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 17, 2020
Risk of physician burnout in the North American allergist-immunologist workforce: A report from the American College of Allergy, Asthma and Immunology Physician Wellness TaskforceGailen D Marshall, Michael Blaiss, Amar Dixit, et al.
Frontiers in Allergy|April 7, 2022
Allergic Rhinitis in Childhood and the New EUFOREA AlgorithmGlenis Kathleen Scadding, Peter Kenneth Smith, Michael Blaiss, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 26, 2022
Dupilumab Efficacy in Patients With Uncontrolled or Oral Corticosteroid-Dependent Allergic and Nonallergic AsthmaGuy Brusselle, Santiago Quirce, Alberto Papi, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 15, 2022
Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic coughPeter V Dicpinigaitis, Surinder S Birring, Michael Blaiss, et al.
The World Allergy Organization Journal|November 8, 2014
ICON: chronic rhinosinusitisClaus Bachert, Ruby Pawankar, Luo Zhang, et al.
American Journal of Rhinology & Allergy|December 22, 2011
Nasal allergies in the Asian-Pacific population: results from the Allergies in Asia-Pacific SurveyConstance H Katelaris, Christopher K W Lai, Chae-Seo Rhee, et al.
American Journal of Rhinology & Allergy|October 14, 2017
Nasal allergies in the Asian-Pacific population: Results from the Allergies in Asia-Pacific SurveyConstance H Katelaris, Christopher K W Lai, Chae-Seo Rhee, et al.
The Journal of Allergy and Clinical Immunology|June 8, 2020
Consensus report from the Food Allergy Research & Education (FARE) 2019 Oral Immunotherapy for Food Allergy SummitAmber N Pepper, Amal Assa'ad, Michael Blaiss, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 15, 2023
Real-world effectiveness of dupilumab in patients with asthma: Findings from the US ADVANTAGE studyMichael Blaiss, Eugene R Bleecker, Juby Jacob-Nara, et al.
The Journal of Allergy and Clinical Immunology|August 26, 2024
Comparative effectiveness of dupilumab and omalizumab on asthma exacerbations and systemic corticosteroid prescriptions: Real-world US ADVANTAGE studyEugene Bleecker, Michael Blaiss, Juby Jacob-Nara, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 17, 2020
Risk of physician burnout in the North American allergist-immunologist workforce: A report from the American College of Allergy, Asthma and Immunology Physician Wellness TaskforceGailen D Marshall, Michael Blaiss, Amar Dixit, et al.
Frontiers in Allergy|April 7, 2022
Allergic Rhinitis in Childhood and the New EUFOREA AlgorithmGlenis Kathleen Scadding, Peter Kenneth Smith, Michael Blaiss, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 26, 2022
Dupilumab Efficacy in Patients With Uncontrolled or Oral Corticosteroid-Dependent Allergic and Nonallergic AsthmaGuy Brusselle, Santiago Quirce, Alberto Papi, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 15, 2022
Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic coughPeter V Dicpinigaitis, Surinder S Birring, Michael Blaiss, et al.
The World Allergy Organization Journal|November 8, 2014
ICON: chronic rhinosinusitisClaus Bachert, Ruby Pawankar, Luo Zhang, et al.
American Journal of Rhinology & Allergy|December 22, 2011
Nasal allergies in the Asian-Pacific population: results from the Allergies in Asia-Pacific SurveyConstance H Katelaris, Christopher K W Lai, Chae-Seo Rhee, et al.
American Journal of Rhinology & Allergy|October 14, 2017
Nasal allergies in the Asian-Pacific population: Results from the Allergies in Asia-Pacific SurveyConstance H Katelaris, Christopher K W Lai, Chae-Seo Rhee, et al.
The Journal of Allergy and Clinical Immunology|June 8, 2020
Consensus report from the Food Allergy Research & Education (FARE) 2019 Oral Immunotherapy for Food Allergy SummitAmber N Pepper, Amal Assa'ad, Michael Blaiss, et al.
Pageof 5